Search filters

Filters
Clear All

Phase

  • 6
  • 4
  • 9
  • 1
  • 4
  • 6
  • 30
  • 4
  • 1
  • 3
  • 26

Found 30 Malignant Adenoma trials

A listing of Malignant Adenoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
Female
Phase 1
Interventional
This study investigates the safety, tolerability, and preliminary effects of an investigational medication combined with gemcitabine in patients with advanced pancreatic cancer. The study is for those who have already been treated with chemotherapy that includes 5-fluorouracil and have not responded to it.Participants will first receive a single dose of …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of total ablative therapy compared to usual systemic therapy in patients with limited metastatic colorectal cancer. Colorectal cancer can spread to other parts of the body, and this study focuses on cases where it has spread to up to four sites. Ablative therapy aims to …
18 years - 80 years
Female
Phase 1/2
Interventional
This study investigates the safety and effectiveness of an investigational imaging agent in female patients who are undergoing surgery for ductal carcinoma in situ (DCIS) or early-stage breast cancer. The purpose of this study is to understand how the imaging agent works in the body and its potential to aid …
18 years or above
Male
Phase 3
Interventional
This study investigates the effectiveness of adding enhanced therapy to standard treatment for prostate cancer patients experiencing biochemical recurrence. The study aims to compare standard prostate radiation therapy combined with short-term androgen deprivation to an enhanced therapy regimen that includes additional medications. Another aspect of the study examines the use …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the effects of an investigational medication on patients with advanced solid tumors that have a KRAS G12D mutation. The purpose is to understand the safety and effectiveness of the investigational medication when used alone and in combination with other treatments.Participants in the study will receive the investigational …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates an investigational medication designed to treat patients with advanced or metastatic solid tumors. The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of this medication both as a standalone treatment and in combination with other agents. The study is focused on …
All genders
Phase 2
Interventional
This study investigates how genetic testing can guide cancer treatment choices for patients with advanced solid tumors. The purpose is to use the genetic information from patients' tumor cells to match them with investigational combination therapies that target specific genetic mutations. This approach aims to control tumor growth and improve …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effects of an investigational radioligand therapy in adults with advanced or metastatic solid tumors that have high levels of fibroblast activation protein (FAP). The study aims to understand how the investigational therapy interacts with FAP. The purpose of this study is to evaluate the …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the use of an investigational medication in patients with advanced solid tumors, specifically focusing on its effects as a single agent or in combination with other therapies. The purpose is to determine the recommended Phase II dose and to evaluate its safety, tolerability, and anti-tumor activity. The …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and imaging characteristics of an investigational fluorescence agent in patients undergoing surgery for lung cancer. The purpose is to evaluate how this agent, administered intravenously, helps visualize tumor margins during surgical procedures. The study focuses on patients with a primary diagnosis or high suspicion of …
21 - 30 of 30